universal transcriptomic – A new Nature study analyzes RNA activity across more than 11,000 tissue transcriptomes from mice, rats, monkeys, and humans, finding aging signatures that stay remarkably consistent across species and cell types. The work links higher “transcriptomic age” to c
Hearts and livers don’t look alike, and neither do the animals they come from. But when researchers looked inside cells—through the RNA instructions that show which genes are switched on or off—they found aging patterns that kept reappearing across species and tissue.
The study. published on Wednesday in the journal Nature. set out to test whether “biological age” leaves consistent molecular fingerprints as time takes its toll. Age isn’t just the number on a birth certificate. Chronological age is the calendar count; biological age reflects how well the body’s tissues and cells are holding up over time—and the two can diverge depending on lifestyle choices. chronic disease. genes. and more.
In the new work. scientists analyzed more than 11. 000 transcriptomes—collections of RNA transcripts that map gene activity in specific cells and tissues at specific moments—across mice. rats. monkeys. and humans. The aim wasn’t only to estimate age. Many existing molecular clocks, including those based on DNA changes, don’t fully explain why aging is happening.
What they found points toward a shared set of “biological hallmarks of aging.” The hallmarks appear to be highly conserved across mammals. meaning they’re carried through different species. Alexander Tyshkovskiy. the paper’s lead author and a researcher at Brigham and Women’s Hospital and Harvard Medical School. said the same genes are linked with aging in. for example. liver and heart in both rats and humans.
The team didn’t stop at tissues. The aging-related biomarkers showed up across individual cell types as well. “Even though the cells have very different functions, very different origin, they still share the same aging-related biomarkers,” Tyshkovskiy added.
The researchers describe this type of aging as “transcriptomic age.” In their data. both humans and animals with chronic diseases had higher transcriptomic age. suggesting it reflects higher levels of cellular damage. They also turned to a large U.K. Biobank dataset and found that transcriptomic age correlates with disease and mortality.
Taken together, the results suggest aging isn’t a slow trickle confined to one organ or cell population. Tyshkovskiy said the process looks “very systemic,” affecting different tissues, cell types, and species in similar ways.
That systemic picture landed as something researchers have long hoped for: a measure that could connect the molecular mechanics of decline to the real-world risks people care about. David Sinclair. a professor at the department of genetics at Harvard Medical School. called the study a “major advance.” Sinclair was not involved with the work. “[The authors] developed transcriptomic clocks that don’t just estimate age; they measure the progressive loss of cellular function and predict biological decline and mortality risk across mammals. ” he said. He added that the findings could help researchers understand “the underlying process of aging itself. not just the passage of time.”.
For now, the clock is a research tool—and the hope is that it becomes a therapeutic roadmap. Tyshkovskiy and colleagues want to turn the fingerprints of transcriptomic age into practical strategies to slow aging in humans.
To move that idea from paper to lab bench, they built an online tool: “Transcriptomic Age Calculator Online,” or TACO. It’s designed to let other researchers predict the age of tissue samples using RNA data they may already have collected. Vadim Gladyshev. the study’s senior author and a professor of medicine at Brigham and Women’s Hospital and Harvard Medical School. said that if a researcher has tissue from one animal model treated with a drug and another model left untreated. the scientist can measure differences in biological age between the samples “regardless of the tissue [and] regardless of the species.”.
That ability matters because human aging research has been stuck on a difficult question: what, exactly, should interventions target?. Gladyshev said. “Currently in humans. we don’t have a single intervention that extends lifespan.” His team’s hope is that. using tools like TACO. researchers can identify candidate treatments that can be tested in the future—and maybe some will extend lifespan.
In an era where longevity science often feels like a patchwork of competing clocks. this one is trying to offer something sturdier: a shared biological signal across species and cell types. detectable from RNA activity. and tightly tied to disease. mortality. and the progressive loss of cellular function.
aging clocks transcriptomic age RNA transcriptomes Nature study longevity research chronic disease cellular damage U.K. Biobank TACO transcriptomic age calculator